Boehringer Ingelheim Pharmaceuticals, Inc.
Member Type
Associate
Organization Type
Manufacturer
Description
Value Through Innovation is Our Vision Improving the health and lives of humans and animals is the goal of the research-driven biopharmaceutical company Boehringer Ingelheim. The focus is on diseases in areas with a high unmet medical need. The company therefore concentrates on developing innovative therapies that can improve and extend lives. In Animal Health, Boehringer Ingelheim is one of the world’s leading providers of vaccines, therapeutics and preventative care offering that protect animals from disease and pain. Family-owned since its foundation in 1885, Boehringer Ingelheim is one of the top 20 companies in the pharmaceutical industry. Our aim is to transform the lives of patients –across generations. This goal inspires all of our over 53,000 employees who create value through innovation. In 2022, Boehringer Ingelheim achieved net sales of 24.1 billion euros.
Contact Information
900 Ridgebury Road
Ridgefield, CT 06877-0368
http://www.boehringer-ingelheim.com(800)344-4095
Services Offered
Branded
HIV/AIDS (HIV)
Staff
-
Kahoro, Ian
Associate Director, Transportation & Customs Compliance, Boehringer Ingelheim Pharmaceuticals, Inc. -
Kaveney, William
Senior NAD, GPO & LTC Pharmacy, Boehringer Ingelheim Pharmaceuticals, Inc. -
Kidner, Tony
Security Director - UK, Boehringer Ingelheim Pharmaceuticals, Inc. -
Lemes, Robson
Regional Deputy Head of Security and Crisis Management – Americas , Boehringer Ingelheim Pharmaceuticals, Inc. -
Marsh, Christine
Vice President, Market Access, Boehringer Ingelheim Pharmaceuticals, Inc. -
Martucci, Brian
HP Country Commercial - Market Access, Boehringer Ingelheim Pharmaceuticals, Inc. -
Masucci, Alfanso
Boehringer Ingelheim Pharmaceuticals, Inc. -
McCarthy, Laurie
Manager, Trade Operations, Boehringer Ingelheim Pharmaceuticals, Inc. -
McGee, Mark
Executive Director US Supply and 3PM North America, Boehringer Ingelheim Pharmaceuticals, Inc. -
McNeish, Stephen
Boehringer Ingelheim Pharmaceuticals, Inc.